| Erythroid Neoplasm studied in …STUDIED_INderived200 of 260show all (up to 200) |
|---|
| → studied in | NCT07722611Phase 2/Phase 3 · recruiting A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05548062active not recruiting Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07839858completed A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469891Phase 1 · recruiting A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429266Phase 3 · recruiting INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07648030Phase 2 · recruiting A Study of Rusfertide in Japanese Adults With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661915Phase 2 · recruiting A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07765602Phase 2 · not yet recruiting A Study of Rusfertide in Adults With Polycythemia Vera in China · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02386800Phase 4 · active not recruiting CINC424A2X01B Rollover Protocol · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05853458Phase 4 · terminated Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07012109Phase 1 · recruiting Study of BEBT-507 Injection in Subjects With Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07232290Phase 2 · recruiting Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02577926Phase 2 · active not recruiting The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361641NA · recruiting Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02071901Phase 2 · completed Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06290765Phase 4 · withdrawn Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06985147Phase 2 · active not recruiting A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07734272NA · not yet recruiting Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03862157Phase 1/Phase 2 · active not recruiting Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04717414Phase 3 · active not recruiting An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093470Phase 3 · completed Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06506084recruiting Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06752941completed LOW-PV Continuation · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07203768recruiting A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00658814Phase 2 · active not recruiting Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07445893NA · recruiting A Clinical Study of Gecacitinib Combined With Pegylated Interferon in Patients With PV · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289910Phase 2 · active not recruiting Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03441113Phase 2 · active not recruiting Extended Access of Momelotinib in Adults With Myelofibrosis · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04517851Phase 2 · active not recruiting Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02493530Phase 1 · completed TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05558696Phase 2 · completed A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116502Phase 3 · recruiting MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878199Phase 1/Phase 2 · terminated Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529951Phase 1 · not yet recruiting Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07518940NA · not yet recruiting ENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06351631Phase 3 · recruiting A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787487Phase 2 · completed Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myeloproliferative Neoplasm · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06063486Phase 2 · recruiting Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06093672Phase 3 · recruiting Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198960Phase 3 · recruiting AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123365Phase 1/Phase 2 · recruiting An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07362225recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341048NA · not yet recruiting Potential Biological and Physiological Determinants for Exercice in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06743035recruiting Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644211Phase 2 · recruiting Ruxolitinib in Thrombocythemia and Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262141Phase 2 · active not recruiting IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00255346Phase 2 · completed Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05499013Phase 1/Phase 2 · active not recruiting Study to Assess SLN124 in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06541249Phase 2 · recruiting MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06421025recruiting Blood Viscosity in Polycythemia Patients · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04745637available Managed Access Programs for INC424, Ruxolitinib · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269771no longer available MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01760655Phase 2 · completed Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551066Phase 3 · terminated To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551053Phase 3 · terminated To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04182100Phase 2 · completed Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04629508Phase 2 · completed To Assess the Safety, Tolerability and Efficacy of Itacitinib Immediate Release Tablets in Participants With Primary or Secondary Myelofibrosis Who Have Received Prior Ruxolitinib and/or Fedratinib Monotherapy (LIMBER-213) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378437Phase 1 · recruiting A Study of GLB-001 in Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05481151Phase 3 · active not recruiting A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04057040Phase 2 · completed Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05210790Phase 3 · active not recruiting A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06033586Phase 3 · active not recruiting Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05485948Phase 2 · active not recruiting A Study to Access Efficacy and Safety of P1101 in Chinese PV Patients Who Are Intolerant or Resistance to HU · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03333486Phase 2 · terminated Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923670NA · not yet recruiting Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06752746Phase 1 · recruiting A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01822015early Phase 1 · completed Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588991Phase 1 · completed Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06798805active not recruiting Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06785870not yet recruiting EVAluation of Erythrocytosis PRospEctive Cohort STudy · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04083170Phase 2 · terminated Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06734637NA · recruiting Efficacy and Safety of Peginterferon in ET and PV. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085408Phase 3 · completed Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03755518Phase 3 · terminated A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04655092Phase 3 · recruiting Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06002490Phase 3 · completed A Study to Evaluate P1101 in Japanese PV Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03003325Phase 2 · completed The Benefit/Risk Profile of AOP2014 in Low-risk Patients With PV · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02760238recruiting Myeloproliferative Neoplasms (MPNs) Patient Registry · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02897297unknown Myeloproliferative Neoplastic Diseases Observatory From Brest · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06134102completed Clinical and Laboratory Characteristics of Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05870475Phase 2 · recruiting Pegylated Interferon α-2b in Combination With Ruxolitinib for Treating Hydroxyurea-resistant/Intolerant PV · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04243122Phase 2 · completed Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251102unknown Real-world Ruxolitinib Experience in PV · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05853445completed A Prospective, Non-interventional Study of JAKAVI® (Ruxolitinib) Treatment in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218628Phase 1 · recruiting Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371573completed Ultrasound Examination for Spleen Volume Evaluation in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01588015Phase 1 · completed Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04767802Phase 2 · completed PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03972943early Phase 1 · terminated CPAP in Treating Obstructive Sleep Apnea in Patients With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01823198Phase 1/Phase 2 · completed Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05993065unknown Hematocrit to Hemoglobin Ratio and Red Blood Cell Distribution Width in Polycythemia Vera and Secondary Erythrocytosis. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05074550Phase 1 · unknown Safety Evaluation Study for Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816256NA · completed Screening for Asymptomatic Portal Vein Thrombosis and Portal Hypertension in Patients With Philadelphia Negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051307Phase 1/Phase 2 · completed Dual Vaccine Trial in Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02124746Phase 2 · completed Long-term Safety and Efficacy of Momelotinib in Subjects With Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Polycythemia Vera or Essential Thrombocythemia · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04896112Phase 1 · withdrawn A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid Leukemia · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02098161Phase 2 · completed LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05882773recruiting Asian Myeloproliferative Neoplasm (MPN) Registry · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03895112Phase 1 · completed MPN-RC 118 AVID200 in Myelofibrosis · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01028716Phase 2 · terminated Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped CURATED_BROADER · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02556931Phase 2 · completed Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04424147Phase 2 · completed Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML · condition mapped CURATED_BROADER · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566535unknown Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01555268Phase 1 · completed Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01168219Phase 2 · completed Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01014546Phase 1 · terminated Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01550185Phase 1 · terminated Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05421104completed Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01387763Phase 3 · completed A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01423851Phase 1/Phase 2 · completed Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00352365Phase 2 · completed Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00369317Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01981850Phase 2 · completed A Phase 2 Study of RO7490677 In Participants With Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00038675NA · completed Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03287245Phase 2 · terminated A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02055781Phase 3 · terminated Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02105116NA · terminated AML Therapy With Irradiated Allogeneic Cells · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02144675Phase 2 · completed Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02038036Phase 3 · completed Ruxolitinib Efficacy and Safety in Patients With HU Resistant or Intolerant Polycythemia Vera vs Best Available Therapy. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03065400Phase 2 · completed PD-1 Inhibition in Advanced Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02218047Phase 3 · completed AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04283526Phase 1 · withdrawn Study of Select Combinations in Adults With Myelofibrosis · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912884completed Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01773187Phase 3 · terminated Pacritinib Versus Best Available Therapy to Treat Myelofibrosis · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01038856Phase 2 · terminated Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03121599NA · terminated 18F-FLT (PET/CT) in Pediatrics With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01235572Phase 2 · completed Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03669965Phase 2 · active not recruiting KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02823184completed Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839240Phase 1 · completed Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998828Phase 2 · terminated Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01787552Phase 1/Phase 2 · completed A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907436NA · completed The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00045435Phase 2 · completed Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00089011Phase 2 · completed Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03745378completed Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00928707Phase 2 · completed Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129101Phase 1 · completed Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715247completed Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01529827Phase 2 · completed Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407080Phase 1 · completed Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02871323Phase 1 · withdrawn Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04054245Phase 2 · withdrawn PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocytosis Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01901432Phase 1/Phase 2 · completed A Two-part Study to Assess the Safety and Preliminary Efficacy of Givinostat in Patients With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02292446Phase 3 · completed Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available. · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666549completed Research Tissue Bank · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946270Phase 2 · completed Pomalidomide for Myelofibrosis Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00895934Phase 1/Phase 2 · completed Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AML · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02311569Phase 2 · completed Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02421354Phase 2 · terminated Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Post-Polycythemia Vera Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02030405Phase 2 · terminated Ixazomib (MLN9708) in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01243944Phase 3 · completed Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01031368Phase 1 · completed Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01849276Phase 1 · terminated Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01093586Phase 2 · completed Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02019069Phase 2 · completed CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00665067completed Correlative Biomarker Study in Patients With Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01499147NA · completed Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904643Phase 1 · terminated Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893410completed Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01253447Phase 2 · completed AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00795002Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01872819NA · completed Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01053494NA · completed Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666588Phase 2 · completed Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia · condition mapped ALIAS · 260 trials mapped (59 active) | — | — | Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835288Phase 2 · withdrawn Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134120Phase 1 · completed A Study in Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801046Phase 1 · terminated Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509899Phase 1/Phase 2 · completed Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01193699Phase 1/Phase 2 · completed Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970930completed Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00445744NA · completed Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049801Phase 1 · terminated MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01831232NA · completed Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01632904Phase 3 · completed Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00101140Phase 2 · withdrawn Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Acute Erythroid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00666289completed Familial Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349972Phase 2 · completed Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462605Phase 2 · completed MS-275 and GM-CSF in Treating Patients With Myelodysplastic Syndrome and/or Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphocytic Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00433862completed Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01342887Phase 1/Phase 2 · terminated Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538980Phase 2 · terminated Dasatinib in Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00673153Phase 2 · terminated Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112593NA · completed Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01427881Phase 2 · completed Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01520220Phase 1 · completed Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01465386Phase 2 · terminated Bortezomib in Treating Patients With High-Risk Acute Myeloid Leukemia in Remission · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01607645Phase 2 · terminated Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052520Phase 1/Phase 2 · completed Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leukemia, or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949805Phase 3 · completed Pegylated Interferon Alpha-2b Versus Hydroxyurea in Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02805868early Phase 1 · withdrawn Siltuximab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelofibrosis · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Polycythemia Vera | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01870596Phase 2 · completed Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active) | — | — | Adult Erythroleukemia | 1 | Observed | clinicaltrials | graph → |